Spero Therapeutics (SPRO) Current Taxes (2023 - 2026)

Spero Therapeutics (SPRO) has reported Current Taxes for 4 consecutive years, with $163000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Current Taxes changed 0.0% year-over-year to $163000.0; the trailing twelve-month figure through Jun 2026 stood at $163000.0 (changed 0.0% YoY), and the FY2025 full-year result was $383000.0, up 120.11% from the prior year.
• Current Taxes was little changed at $163000.0 in Q2 2026 per SPRO's latest filing, from $163000.0 in the prior quarter.
• Across five years, Current Taxes topped out at $2.2 million in Q3 2023 and bottomed at $97000.0 in Q3 2024.
• Historically, Current Taxes has averaged $404333.3 across 4 years, with a median of $174000.0 in 2024.
• The sharpest annual moves came in 2024 and 2025: Current Taxes plunged 95.61% in 2024, then soared 120.11% in 2025.
• Over 4 years, Current Taxes stood at $387000.0 in 2023, then slumped by 55.04% to $174000.0 in 2024, then jumped by 120.11% to $383000.0 in 2025, then tumbled by 57.44% to $163000.0 in 2026.
• According to Business Quant data, Current Taxes over the past three periods registered $163000.0, $163000.0, and $383000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.